Video Creative
ACST Historical Stock Prices ยป
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Acasti Pharma is a biopharmaceutical company based in Canada. Co. is engaged in the research, development and commercialization of new therapies for abnormalities in blood lipids, referred to as dyslipidemia, and the treatment and prevention of cardiovascular disorders. Co.'s products are derived from krill oil. Co.'s products include: CaPre® is for prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia; and Onemia™ is for cardiometabolic disorders treatments. Co. sells its products primarily in Canada and the U.S. According to our ACST split history records, Acasti Pharma has had 2 splits.
ACST split history picture
Acasti Pharma (ACST) has 2 splits in our ACST split history database. The first split for ACST took place on December 12, 2003. This was a 1 for 89 reverse split, meaning for each 89 shares of ACST owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 11.2359550561798 share position following the split. ACST's second split took place on October 15, 2015. This was a 1 for 10 reverse split, meaning for each 10 shares of ACST owned pre-split, the shareholder now owned 1 share. For example, a 11.2359550561798 share position pre-split, became a 1.12359550561798 share position following the split.

When a company such as Acasti Pharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the ACST split history from start to finish, an original position size of 1000 shares would have turned into 1.12359550561798 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acasti Pharma shares, starting with a $10,000 purchase of ACST, presented on a split-history-adjusted basis factoring in the complete ACST split history. ACST split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/07/2012
End date: 01/22/2018
Start price/share: $12.10
End price/share: $1.13
Dividends collected/share: $0.00
Total return: -90.66%
Average Annual Total Return: -32.81%
Starting investment: $10,000.00
Ending investment: $934.23
Years: 5.96
Date Ratio
12/12/20031 for 89
10/15/20151 for 10
ACST is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ACUR Split History
ADAP Split History
ADK Split History
ADMP Split History
ADMS Split History
ADPT Split History
ADXS Split History
AEZS Split History
AFAM Split History
AFFX Split History

More latest